Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
5m agoZacks Small-Cap Research Raises FatPipe (NASDAQ:FATN) Valuation from $6.00 to $6.40 per Share Following Preliminary Fiscal Fourth Quarter Business Update
5m agoMEDX HOLDINGS ANNOUNCES Q1 2026 HIGHLIGHTS, MULTI-CITY EXPANSION, AND CORPORATE ACTION TO REBRAND AS DAZED INC. (TICKER: DAZE)
5m agoVS Media Enters the AI Smart Living Sector to Explore New Growth Opportunities
32m agoGalderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
32m agoSurface Transforms plc – in Administration, Sale of Business and Assets
Pyc Therapeutics Limited logo

Pyc Therapeutics Limited

About

1.36AUD+0.06 +4.21%
Closed • Updated at 17:07 GMT+00:00
Market Cap$916.78M
Volume1.36M
Beta1.29
RSI56.66
Health TechnologyPharmaceuticals: Major

Pyc Therapeutics Limited — investor relations, events, news, and company updates on 6ix.

Latest News

May 7 2026
PKD - Initiation of Multiple Dose Clinical Trial
May 4 2026
Presentation of Ophthalmology Clinical Trial Data at ARVO
Apr 15 2026
ADOA Program - SRC Approve Progression to Multi-Dose Study
Mar 4 2026
Completion of Retail Entitlement Offer
Feb 27 2026
PKD Clinical Trial - Approval to Escalate Dosing

Community Chat

Ask AI

6ix6ixAIEvents